Latest News
Calidi Biotherapeutics, Inc.
- Calidi Biotherapeutics to Present New CLD-401 Data and In Situ TCE Platform Advances at the ESMO Congress 2026
- Mouse data will show high rates of complete tumor elimination with Calidi's tumor-targeting virus.
- Calidi Biotherapeutics to present new tumor-tar...
- Calidi Biotherapeutics (NYSEAMERICAN:CLDI) Races to Fix an Equity Shortfall Before Delisting
- Calidi Biotherapeutics gets NYSE compliance warning but stock surprises
- Calidi Biotherapeutics Received Notice of Noncompliance
- Calidi Biotherapeutics Received NYSE American Notification Letter Regarding Stockholders’ Equity Deficiency
Headlines from the last 30 days, linking to the original publishers. See all market news →